Banque Pictet & Cie Sa Gilead Sciences, Inc. Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

A detailed history of Banque Pictet & Cie Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 5,500 shares of GILD stock, worth $505,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,500

Previous 5,500 -0.0%

Holding current value

$505,120

Previous $377,000 22.28%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $144,781 - $164,185	-1,976 Reduced 26.43%	5,500 $445,000
Q3 2023 Nov 02, 2023	SELL	$73.94 - $80.67 $306,998 - $334,941	-4,152 Reduced 35.71%	7,476 $560,000
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $68,637 - $78,290	-903 Reduced 7.21%	11,628 $896,000
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $220,642 - $251,380	-2,854 Reduced 18.55%	12,531 $1.04 Million
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $181,164 - $260,089	-2,907 Reduced 15.89%	15,385 $0
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $543,600 - $620,931	-9,130 Reduced 33.29%	18,292 $1.13 Billion
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $2.88 Million - $3.24 Million	-49,893 Reduced 64.53%	27,422 $1.7 Million
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $1.94 Million - $2.44 Million	33,558 Added 76.69%	77,315 $4.6 Million
Q4 2021 Feb 02, 2022	BUY	$64.88 - $73.64 $40,939 - $46,466	631 Added 1.46%	43,757 $3.18 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $23,691 - $25,560	350 Added 0.82%	43,126 $3.01 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $190,410 - $208,049	-3,000 Reduced 6.55%	42,776 $2.95 Million
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $819,000 - $934,478	-13,650 Reduced 22.97%	45,776 $2.96 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $133,920 - $152,596	-2,364 Reduced 3.83%	59,426 $3.46 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $347,760 - $437,248	-5,600 Reduced 8.31%	61,790 $3.91 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $714,791 - $830,004	-9,881 Reduced 12.79%	67,390 $5.19 Million
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $5.36 Million - $6.86 Million	-85,548 Reduced 52.54%	77,271 $5.78 Million
Q4 2019 Feb 03, 2020	BUY	$61.62 - $67.78 $165,449 - $181,989	2,685 Added 1.68%	162,819 $10.6 Million
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $363,183 - $400,890	5,810 Added 3.76%	160,134 $10.1 Million
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $568,399 - $637,394	9,187 Added 6.33%	154,324 $10.4 Million
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $825,458 - $924,730	-13,201 Reduced 8.34%	145,137 $9.44 Million
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $249,122 - $325,085	4,115 Added 2.67%	158,338 $9.9 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $109,913 - $121,694	1,542 Added 1.01%	154,223 $11.9 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $1.2 Million - $1.4 Million	18,527 Added 13.81%	152,681 $10.8 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $163,380 - $199,178	-2,243 Reduced 1.64%	134,154 $10.1 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $976,035 - $1.15 Million	-13,718 Reduced 9.14%	136,397 $9.77 Million
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $3.91 Million - $4.64 Million	-54,241 Reduced 26.54%	150,115 $12.2 Million
Q2 2017 Aug 09, 2017	BUY	N/A	204,356	204,356 $14.5 Million

Others Institutions Holding GILD

# of Institutions

1,941

Shares Held

989M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Gilead Sciences, Inc. Transaction History